ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
Abstract Background The treatment with short-acting beta-2 agonists (SABA) alone is no longer recommended due to safety issues. Instead, the current Global Initiative for Asthma (GINA) Report recommends the use of the combination of inhaled corticosteroids (ICS) with the rapid/long-acting beta-2 ago...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-01-01
|
| Series: | Asthma Research and Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40733-021-00067-z |